Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this study, targeted overexpression of the BMP receptor ALK2 in mouse hair follicle stem cells altered follicle structure and impaired cutaneous wound healing.

This study reports that the composite galeal frontalis pericranial flap can be successfully used for reconstruction in anterior cranial base surgery, effectively sealing cerebrospinal fluid leaks, while minimizing complications like numbness and skin necrosis.

This notice corrects an article on fluridil for androgenetic alopecia, indicating potential conflicts of interest due to the authors' patent holdings and funding source; it reports no new research findings.

In this study, replacing the original pin with a different one on a larger cupola improved pseudo alopecia areata lesions in 58.8% of patients.

This study presents case reports of four patients with alopecia areata or alopecia universalis, highlighting varied responses to treatments like prednisone, intralesional triamcinolone, and squaric acid dibutyl ester.

This study reported that allethrin caused dose-dependent toxico-pathological effects, including decreased feed intake, body weight, and blood parameters, and organ damage in adult male albino rats.

This study found that anagen stage protein homogenates and specific epitopes from melanogenesis proteins activated CD8 T cells, suggesting alopecia areata is an anagen-specific disease.

Treating alopecia effectively requires combining medical, cosmetic, and barbering methods for both physical and emotional well-being.

This review discusses the clinical, epidemiological, and pathophysiological aspects of female pattern hair loss and reports no new experimental findings.

This review found that platelet-rich plasma treatment is effective for androgenetic alopecia, significantly increasing hair diameter in both sexes, but only improving hair density in men.

This study found that alopecia areata significantly impacts patients' quality of life irrespective of hair loss severity, and concluded that the newer assessment tools AAPPO and AASIS better capture this impact compared to the traditional SALT measure.

This study found that Egyptian patients with alopecia areata had a significant presence of sensorineural hearing loss compared to controls, correlated with the severity, duration, and recurrence of the disease.

In this study, researchers reported significantly higher serum calprotectin levels in alopecia areata patients compared to controls and that these levels were associated with the disease's severity, type, duration, and nail involvement, suggesting calprotectin as a potential marker for inflammation in these patients.

People with alopecia areata may have a higher risk of hearing loss.

In this phase 3 trial, baricitinib showed effectiveness and safety in both adolescents and adults with severe alopecia areata, with adolescents achieving higher response rates despite more severe baseline conditions, suggesting the advantages of early treatment.

This paper presents a therapeutic approach with excellent results in a case of lichen planopilaris overlapping with dermatomyositis and scleroderma, although broader applicability is not discussed.

This integrative review found that triamcinolone hexacetonide remains the primary treatment for mild to moderate alopecia areata but noted its significant side effects with prolonged use, while emerging therapies like PRP and minoxidil offer promising alternative benefits with fewer risks.

This literature review found that among therapies for Alopecia Areata, Janus kinase inhibitors are particularly promising despite safety challenges, while newer approaches like stem cells face cost and complexity issues; a comprehensive approach integrating medical and emotional support was emphasized for improving patient outcomes.

In this study, Brazilian dermatologists reported that patients with alopecia areata, particularly those with severe scalp hair loss, often experience an unmet need for advanced therapies that could improve treatment outcomes beyond the limitations of current options.

This study reviewed current scientific evidence on how scalp microbiome alterations may affect hair growth, citing connections to inflammatory and immune processes and suggesting potential for therapeutic targeting, though further studies are needed to confirm clinical applications.

AI can accurately measure hair loss severity in alopecia areata.

This study reported that a frontoplasty endoscopic subperiosteal technique using three small incisions was effective and aesthetically beneficial in treating upper facial aging among patients with frontotemporal alopecia, though it did result in some minor complications such as eyebrow correction issues and recurring glabellar wrinkles.

This research presents the Dodatek A model, elaborating on androgen function through new mathematical indices and methodological improvements, shifting focus from serum hormone concentrations to system interactions to better describe androgen activity comprehensively.

Alopecia areata significantly strains healthcare and finances in the UAE, needing better management.